documents: FDA-2022-N-2226-0019
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-N-2226-0019 | FDA | FDA-2022-N-2226 | Reference 24 - *FDA, “Use of Salt Substitutes to Reduce the Sodium Content in Standardized Foods” Preliminary Regulatory Impact Analysis, Initial Regulatory Flexibility Analysis, Unfunded Mandates Reform Act Analysis. Available at https://www.fda.gov/about-fda/reports/economic-impact-analyses-fda-regulations RE Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods | Supporting & Related Material | Background Material | 2023-04-10T04:00:00Z | 2023 | 4 | 2023-04-10T19:11:41Z | 0 | 0 | 090000648591ce1d |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref